Filing Details

Accession Number:
0001127602-21-028439
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-05 14:15:13
Reporting Period:
2021-11-04
Accepted Time:
2021-11-05 14:15:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1741585 Marie Johonna Pelletier C/O Conmed Corporation
11311 Concept Boulevard
Largo FL 33773
Treasurer And Vp, Tax No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-11-04 1,247 $154.14 2,634 No 4 S Direct
Common Stock Acquisiton 2021-11-04 5,400 $78.76 8,034 No 4 M Direct
Common Stock Disposition 2021-11-04 5,400 $154.56 2,634 No 4 S Direct
Common Stock Acquisiton 2021-11-04 2,550 $97.69 5,184 No 4 M Direct
Common Stock Disposition 2021-11-04 2,550 $154.62 2,634 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options To Purchase Common Stock Disposition 2021-11-04 5,400 $0.00 5,400 $78.76
Common Stock Options To Purchase Common Stock Disposition 2021-11-04 2,550 $0.00 2,550 $97.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,100 2029-03-01 No 4 M Direct
10,200 2030-03-02 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.53 to $154.64. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  2. The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period